Nutra Pharma Corp (NPHC) Restructuring Costs (2025 - 2026)

Nutra Pharma has disclosed Restructuring Costs across 2 years of filings, most recently posting $30250.0 for Q2 2026.

• In Q2 2026, Restructuring Costs rose 8.7% year-over-year to $30250.0; the TTM figure through Jun 2026 stood at $112514.0 (changed N/A YoY), while the FY2025 annual figure was $115512.0, up 13.79% from the prior year.
• Restructuring Costs came in at $30250.0 for Q2 2026 at Nutra Pharma, up from $24450.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $30250.0 in Q2 2026 to a low of $24450.0 in Q1 2026.